# GraniteShares Platinum Trust: financial statements, quarterly

PLTM · NYSE · CIK 1690842 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/pltm.md) · [Financials](/companies/pltm/financials.md) · [Filings](/companies/pltm/filings.md) · [Insiders](/companies/pltm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pltm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [1.3](/filings/0001493152-24-044162.md) | [3.3](/filings/0001493152-25-004701.md) | [(3.9)](/filings/0001641172-25-009284.md) | [4.2 d](/filings/0001493152-26-037704.md) | [(1.2)](/filings/0001493152-25-020707.md) | [(3.4)](/filings/0001493152-26-005002.md) | [4.0](/filings/0001493152-26-021844.md) | [20.7 d](/filings/0001493152-26-037704.md) | [15.8](/filings/0001493152-25-020707.md) | [39.2](/filings/0001493152-26-005002.md) | [(25.7)](/filings/0001493152-26-021844.md) | [(36.3) d](/filings/0001493152-26-037704.md) |
| Diluted EPS | $ per share | [0.31](/filings/0001493152-24-044162.md) | [0.80](/filings/0001493152-25-004701.md) | [(0.96)](/filings/0001641172-25-009284.md) | not reported | [(0.27)](/filings/0001493152-25-020707.md) | [(0.71)](/filings/0001493152-26-005002.md) | [0.75](/filings/0001493152-26-021844.md) | not reported | [2.26](/filings/0001493152-25-020707.md) | [4.12](/filings/0001493152-26-005002.md) | [(1.90)](/filings/0001493152-26-021844.md) | not reported |
| Basic EPS | $ per share | [0.31](/filings/0001493152-24-044162.md) | [0.80](/filings/0001493152-25-004701.md) | [(0.96)](/filings/0001641172-25-009284.md) | not reported | [(0.27)](/filings/0001493152-25-020707.md) | [(0.71)](/filings/0001493152-26-005002.md) | [0.75](/filings/0001493152-26-021844.md) | not reported | [2.26](/filings/0001493152-25-020707.md) | [4.12](/filings/0001493152-26-005002.md) | [(1.90)](/filings/0001493152-26-021844.md) | not reported |

- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [36.3](/filings/0001493152-23-039290.md) | [39.6](/filings/0001493152-24-004707.md) | [36.5](/filings/0001493152-24-018269.md) | [43.1](/filings/0001493152-25-011791.md) | [41.9](/filings/0001493152-24-044162.md) | [45.9](/filings/0001493152-25-004701.md) | [50.3](/filings/0001641172-25-009284.md) | [88.5](/filings/0001493152-26-037704.md) | [133](/filings/0001493152-25-020707.md) | [234](/filings/0001493152-26-005002.md) | [221](/filings/0001493152-26-021844.md) | [164](/filings/0001493152-26-037704.md) |
| Total liabilities | $m | [0.0](/filings/0001493152-23-039290.md) | [0.0](/filings/0001493152-24-004707.md) | [0.0](/filings/0001493152-24-018269.md) | [0.0](/filings/0001493152-25-011791.md) | [0.0](/filings/0001493152-24-044162.md) | [0.0](/filings/0001493152-25-004701.md) | [0.0](/filings/0001641172-25-009284.md) | [3.3](/filings/0001493152-26-037704.md) | [3.8](/filings/0001493152-25-020707.md) | [0.1](/filings/0001493152-26-005002.md) | [0.1](/filings/0001493152-26-021844.md) | [0.1](/filings/0001493152-26-037704.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4.6](/filings/0001493152-24-004707.md) | [4.7](/filings/0001493152-24-018269.md) | [4.1](/filings/0001493152-24-044162.md) | [4.1](/filings/0001493152-25-004701.md) | [4.1](/filings/0001641172-25-009284.md) | [4.4](/filings/0001493152-25-020707.md) | [4.7](/filings/0001493152-26-005002.md) | [5.3](/filings/0001493152-26-021844.md) | [7.0](/filings/0001493152-25-020707.md) | [9.5](/filings/0001493152-26-005002.md) | [13.5](/filings/0001493152-26-021844.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 10,900,000 at 2026-08-13, from the cover of the [10-K filed 2026-08-13](/filings/0001493152-26-037704.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.